How many Axsome Therapeutics shares are in issue?
Axsome Therapeutics has 47,320,000 shares in issue.
What is the market cap of Axsome Therapeutics?
The market capitalisation of Axsome Therapeutics is USD 158.52 M.
What is the 1 year trading range for Axsome Therapeutics share price?
Axsome Therapeutics has traded in the range of US$ 3.35 to US$ 3.35 during the past year.
What is the PE ratio of Axsome Therapeutics?
The price to earnings ratio of Axsome Therapeutics is -20.10.
What is the cash to sales ratio of Axsome Therapeutics?
The cash to sales ratio of Axsome Therapeutics is 17.77.
What is the reporting currency for Axsome Therapeutics?
Axsome Therapeutics reports financial results in USD.
What is the latest annual turnover for Axsome Therapeutics?
The latest annual turnover of Axsome Therapeutics is USD 270.6M.
What is the latest annual profit for Axsome Therapeutics?
The latest annual profit of Axsome Therapeutics is USD -239.24M.
What is the registered address of Axsome Therapeutics?
The registered address for Axsome Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808.
What is the Axsome Therapeutics website address?
The website address for Axsome Therapeutics is www.axsome.com.
Which industry sector does Axsome Therapeutics operate in?
Axsome Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
